Trevi Therapeutics Inc (NAS:TRVI)
$ 3.02 -0.02 (-0.66%) Market Cap: 219.23 Mil Enterprise Value: 152.38 Mil PE Ratio: 0 PB Ratio: 3.32 GF Score: 41/100

Q1 2024 Trevi Therapeutics Inc Earnings Call Transcript

May 07, 2024 / 08:30PM GMT
Release Date Price: $2.9 (-1.36%)
Operator

Good afternoon and welcome to the Trevi Therapeutics First Quarter 2024 earnings conference call. At this time, all participants will be in a listen only mode. Should you need assistance please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question. You may press star then one on your phone. To withdraw your question, please press star one to Please note this event is being recorded. Various remarks that management makes during this conference call about the Company's future expectations, plans and prospects constitute forward-looking statements for purposes of the Safe Harbor Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ material materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of the company's most recent quarterly report on Form 10 Q was the Company filed with the SEC this afternoon. In addition, any forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot